Receptos, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 16 of 16 Posts
Don’t Get Caught When This Bubble Bursts
Article By: Bret Jensen Tuesday, July 21, 2015 10:18 PM EDT
The enthusiasm for the small cap biotech sector is quite something right now. This is understandable given the top gainers within the market during the first half of 2015 is dominated by names from this space but this sort of rally cannot continue.
In this article: CELG, EGRX, GILD, HALO, JUNO, RCPT, SGYP, ZIOP
Read
Biotech Mania: Another Deal, Another Rally To New Highs
Article By: Rod Raynovich Thursday, July 16, 2015 11:20 PM EDT
The market mentality now is that by the end of the year more multi-$B deals will be struck so companies with later stage biotech pipelines will outperform the market. For now don’t fight momentum don’t fight the FED.
In this article: ABBV, CELG, GILD, IBB, PCYC, RCPT, REGN, XBI, XLV
Read
Analysts Provide Insight On Celgene Corporation And Receptos, Inc. In Light Of Acquisition Announcement
Article By: TipRanks Thursday, July 16, 2015 11:08 AM EDT
Celgene will pay $7.2 billion in cash for the autoimmune drug maker. The boards of both companies have approved the terms of the acquisition and expect it to close before the end of the quarter.
In this article: CELG, RCPT
Read
Receptos - Chart Of The Day
Article By: Jim Van Meerten Wednesday, July 15, 2015 8:44 PM EDT
Since the Trend Spotter signaled a buy on 5/12 the stock gained 37.49%.
In this article: RCPT
Read
E Celgene To Buy Receptos For $7.3B In All Cash Acquisition
Article By: Terry Chrisomalis Tuesday, July 14, 2015 6:26 PM EDT
Celgene is paying $232 per share or $7.3B in cash to acquire Receptos. CELG up almost 6%AH.
In this article: CELG, RCPT
Read
Biopharmaceutical Summer Highlights: Intercept Pharmaceuticals Inc., Receptos Inc., And XOMA Corp.
Article By: TipRanks Sunday, July 5, 2015 10:36 AM EDT
Liana Moussatos of Wedbush released a report highlighting a list of upcoming catalysts for Intercept Pharmaceuticals Inc., Receptos Inc., and XOMA Corp.
In this article: ICPTF, RCPT, XOMA
Read
Biotechs Lead Nasdaq To Record High: BMRN, AMGN, RCPT, MDVN, BIIB, KITE
Article By: Andy Wang Thursday, June 18, 2015 11:36 PM EDT
Biotech stocks jumped higher today pushing Nasdaq to a record high at 5133. Yesterday, after the market, BMRN shares popped higher, as the company reported positive results from a mid-stage study for its drug to treat the most common form of dwarfism
In this article: AMGN, AMZN, BA, BIIB, BMRN, CELG, CRM, INCY, ISIS, JAZZ, KITE, MDVN, MNST, RCPT
Read
Monday Morning Pre-Market Insights: MNKD, SDRL, RCPT, PTBI
Article By: TipRanks Monday, June 8, 2015 8:27 AM EDT
Monday Morning Pre-Market Insights: MannKind Corporation, Seadrill Ltd, Receptos, Inc., Plasmatech Biopharmaceuticals, Inc.
In this article: MNKD, SDRL, RCPT, PTBI
Read
Wedbush Highlights Upcoming Catalysts In The Pharmaceutical Sector
Article By: TipRanks Sunday, June 7, 2015 6:11 AM EDT
On June 2, Wedbush analyst Liana Moussatos published a list of upcoming catalysts for emerging pharmaceuticals, specifically for Intercept Pharmaceuticals Inc, Receptos Inc, and Omeros Corporation.
In this article: ICPT, RCPT, OMER
Read
Sector Rotation Model Stays Bullish, But Neutral Rankings And Technical Resistance Flash Caution
Article By: Sabrient Systems Monday, April 27, 2015 12:23 PM EDT
Last week, stocks cycled bullish yet again. In fact, the S&P 500, NYSE Composite, and NASDAQ each closed at record highs as investors positioned for the heart of earnings season in the wake of strong reports from some of the Tech giants.
In this article: SPY, RCPT, CRUS, SHPG, LVLT, EXC, CAVM, IYW, IYH, IYE, IDU
Read
Upcoming Events In Biotechnology: OVAS, ICPT, TTPH, RCPT
Article By: TipRanks Tuesday, April 7, 2015 9:38 AM EDT
On April 6, analysts at Wedbush led by Liana Moussatos highlighted upcoming events in the biotech sector. Here is what to watch for:
In this article: OVAS, TTPH, ICPT, RCPT
Read
Provectus Biopharmaceuticals Concludes FDA Meeting For PV-10 Phase 3; Successful Completion Of AB Science's Futility Test For Masitinib
Article By: BioMedReports Tuesday, February 10, 2015 5:59 AM EDT
Here is a look at some of the headlines for companies that made news in the healthcare sector on February 9, 2015.
In this article: ACHN, AKBS, AKR.L, AVXL, BIOC, BMRN, BSDM, CLDX, CBMG, CEMI, ENSG, GALE, ICUI, ISLT, IART, JUNO, LJPC, LFVN, MJNA, HTGC, NSPH, OREX, RDHL.TA, RCPT, RGLS, RNN, SBRA, WMGI, VBLT
Read
5 Best Performing Russell 2000 Stocks Of 2014
Article By: Zacks Investment Research Tuesday, December 23, 2014 11:13 AM EDT
The Russell 2000 Index has lagged all the major benchmarks for most part of this year. As of Dec 22, the index has returned only 3.3%.
In this article: GTIV, UEIC, FLWS, SKH, AVNR, OVAS, RCPT, ACHN, TGTX, FOLD, PTX, AMRE
Read
Insider Trading Report Edition #230: Notable Buys And Sales
Article By: Asif Suria Sunday, November 16, 2014 4:19 PM EDT
Insider buying decreased last week with insiders buying $73.83 million of stock compared to $90.85 million in the week prior. Selling also decreased with insiders selling $1.67 billion of stock last week compared to $2.18 billion in the week prior.
In this article: CHK, HAS, LF, NMFC, P, SCHW, X, TRUE, PSEC, REGN, FNFG, MDRX, MEMP, NOW, RCPT, TPUB
Read
Active Stocks: Columbia Laboratories, Neurometrix, Cynosure, Receptos, Bristol-Myers
Article By: BioMedReports Tuesday, October 28, 2014 5:38 PM EDT
U.S. stocks climbed in afternoon trading on Tuesday, following stronger-than-expected earnings and an upbeat consumer confidence reading.
In this article: BMY, CBRX, CYNO, NURO, RCPT
Read
Chart Of The Day - Receptos (RCPT)
Article By: Jim Van Meerten Sunday, January 26, 2014 10:38 PM EDT
Receptos, Inc. is a biopharmaceutical company. It develops therapeutic for the treatment of immune and metabolic diseases. It hit an all time high on Friday.
In this article: RCPT
Read
1 to 16 of 16 Posts